Renshi Li

807 total citations
47 papers, 621 citations indexed

About

Renshi Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Renshi Li has authored 47 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 6 papers in Complementary and alternative medicine. Recurrent topics in Renshi Li's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Cannabis and Cannabinoid Research (3 papers). Renshi Li is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Cannabis and Cannabinoid Research (3 papers). Renshi Li collaborates with scholars based in China, Japan and Singapore. Renshi Li's co-authors include Chaofeng Zhang, Kuniyoshi Shimizu, Xiaobing Wang, Ling‐Yi Kong, Xiaojun Hu, Haifeng Xie, Boyang Yu, Yongrong Yao, Jinyu Yang and Jiangwei Tian and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Renshi Li

45 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renshi Li China 13 213 117 114 60 55 47 621
Jinping Gu China 20 441 2.1× 128 1.1× 58 0.5× 49 0.8× 89 1.6× 47 989
Shikha Sharma India 17 236 1.1× 76 0.6× 79 0.7× 27 0.5× 54 1.0× 44 837
Giovanni Paolo Cetrangolo Italy 9 286 1.3× 40 0.3× 48 0.4× 40 0.7× 91 1.7× 15 707
Amir Shadboorestan Iran 16 266 1.2× 59 0.5× 55 0.5× 26 0.4× 52 0.9× 50 693
Kyeong‐Ryoon Lee South Korea 16 239 1.1× 68 0.6× 40 0.4× 57 0.9× 26 0.5× 70 790
Liwei Gu China 18 348 1.6× 65 0.6× 29 0.3× 28 0.5× 26 0.5× 46 747
Müslüm Kuzu Türkiye 14 268 1.3× 132 1.1× 53 0.5× 10 0.2× 39 0.7× 39 784
Hamid Ceylan Türkiye 17 259 1.2× 75 0.6× 49 0.4× 69 1.1× 63 1.1× 40 678
Kiruthika Sundarraj India 12 501 2.4× 100 0.9× 58 0.5× 12 0.2× 70 1.3× 12 889
Huaizhen He China 14 256 1.2× 69 0.6× 16 0.1× 37 0.6× 93 1.7× 66 692

Countries citing papers authored by Renshi Li

Since Specialization
Citations

This map shows the geographic impact of Renshi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renshi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renshi Li more than expected).

Fields of papers citing papers by Renshi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renshi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renshi Li. The network helps show where Renshi Li may publish in the future.

Co-authorship network of co-authors of Renshi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Renshi Li. A scholar is included among the top collaborators of Renshi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renshi Li. Renshi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tao, Minli, Xiaodong Yan, Xinxin Fan, et al.. (2025). Acidic polysaccharide CP-2 from Dioscoreae Rhizoma ameliorated acute alcoholic liver injury through the gut-liver axis and AMPK/PPAR pathway. International Journal of Biological Macromolecules. 310(Pt 2). 143145–143145. 2 indexed citations
3.
Zou, Xing, Takumi Ishida, Renshi Li, et al.. (2025). Ablation of Mouse Selenium-Binding Protein 1 and 2 Elevates LDL by Disruption of Cholesterol Efflux and Lipid Metabolism. International Journal of Molecular Sciences. 26(7). 3363–3363. 1 indexed citations
4.
Li, Renshi, et al.. (2024). Timeframe Analysis of Novel Synthetic Cannabinoids Effects: A Study on Behavioral Response and Endogenous Cannabinoids Disruption. International Journal of Molecular Sciences. 25(6). 3083–3083. 1 indexed citations
5.
Ma, Renqiang, Sijia Li, Xiaojuan Chen, et al.. (2024). Preventive and Therapeutic Effects of Crocetin in Rats with Heart Failure. Pharmaceuticals. 17(4). 496–496. 1 indexed citations
6.
Ma, Yajie, et al.. (2024). Oligosaccharides fromAsparagus cochinchinensisfor ameliorating LPS-induced acute lung injury in mice. Food & Function. 15(5). 2693–2705. 4 indexed citations
7.
Wang, Xiaoyan, et al.. (2024). Protection effect of Dioscoreae Rhizoma against ethanol-induced gastric injury in vitro and in vivo: A phytochemical and pharmacological study. Journal of Ethnopharmacology. 333. 118427–118427. 6 indexed citations
8.
Li, Zhongrui, Haili Zhang, Yu Zhao, et al.. (2024). Berberine-based self-assembly agents with enhanced synergistic antitumor efficacy. Frontiers in Pharmacology. 15. 1333087–1333087. 2 indexed citations
9.
Shi, Wen, et al.. (2023). Specneuzhenide improves bleomycin-induced pulmonary fibrosis in mice via AMPK-dependent reduction of PD-L1. Phytomedicine. 128. 155318–155318. 7 indexed citations
10.
Ding, Yue, Lei Wang, Zheng‐Guo Cui, et al.. (2023). Ginseng saponin metabolite 20(S)-protopanaxadiol relieves pulmonary fibrosis by multiple-targets signaling pathways. Journal of Ginseng Research. 47(4). 543–551. 10 indexed citations
11.
Gao, Han, Lei Sun, Jiwei Li, et al.. (2023). Illumination of Hydroxyl Radical in Kidney Injury and High‐Throughput Screening of Natural Protectants Using a Fluorescent/Photoacoustic Probe. Advanced Science. 10(33). e2303926–e2303926. 36 indexed citations
13.
Chen, Ce, Liang Han, Jiaoyang Wang, et al.. (2022). Heterophyllin B an Active Cyclopeptide Alleviates Dextran Sulfate Sodium‐Induced Colitis by Modulating Gut Microbiota and Repairing Intestinal Mucosal Barrier via AMPK Activation. Molecular Nutrition & Food Research. 66(17). e2101169–e2101169. 10 indexed citations
15.
Liu, Bei, Jinyu Yang, Haifeng Xie, et al.. (2021). Natural product mogrol attenuates bleomycin-induced pulmonary fibrosis development through promoting AMPK activation. Journal of Functional Foods. 77. 104280–104280. 17 indexed citations
17.
Ding, Yue, et al.. (2020). Functional Food XingJiuTang Attenuates Alcohol‐Induced Liver Injury by Regulating SIRT1/Nrf‐2 Signaling Pathway. Chemistry & Biodiversity. 17(12). e2000619–e2000619. 2 indexed citations
18.
Liu, Bei, et al.. (2019). Protective Effect of the Traditional Chinese Patent Medicine Qing‐Xuan Granule against Bleomycin‐Induced Pulmonary Fibrosis in Mice. Chemistry & Biodiversity. 16(12). e1900467–e1900467. 12 indexed citations
20.
Li, Renshi, Xiaobing Wang, Xiaojun Hu, & Ling‐Yi Kong. (2013). Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 23(9). 2636–2641. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026